Acknowledgement
The EAS CVD Risk Checkpoint has been funded by Novartis Pharma AG. However, Novartis has not had any input into the content or development of this initiative. The data gathered from the CVD Risk Checkpoint will be analysed to produce an aggregated anonymised summary report, which will be shared with Novartis.
Check your own Cardiovascular health during the Congress
As part of its ongoing mission to promote cardiovascular health, the European Atherosclerosis Society is offering a free CV health check during the Congress through the EAS CVD Risk Checkpoint, located in the exhibition area.
Congress participants are invited to assess key risk markers, including lipoprotein(a) [Lp(a)], low-density lipoprotein cholesterol (LDL-C), glycated haemoglobin (HbA1c), and blood pressure.
Don’t miss the opportunity to take part in this important health initiative, gain insights into your cardiovascular risk profile, and contribute to a broader research project.
